Research programme: systemic small molecule therapeutics - Ventus Therapeutics
Latest Information Update: 11 Mar 2024
At a glance
- Originator Ventus Therapeutics
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Gastrointestinal disorders; Immunological disorders
Most Recent Events
- 28 Feb 2024 Early research in Gastrointestinal disorders in USA (unspecified route) prior to February 2024 (Ventus Therapeutics pipeline, February 2024)
- 28 Feb 2024 Early research in Immunological disorders in USA (unspecified route) prior to February 2024 (Ventus Therapeutics pipeline, February 2024)